Humana Inc. (NYSE:HUM - Get Free Report) declared a quarterly dividend on Thursday, October 29th. Investors of record on Thursday, December 24th will be given a dividend of $0.8850 per share by the insurance provider on Friday, January 29th. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, December 24th.
Humana has increased its dividend by an average of 0.1% per year over the last three years. Humana has a dividend payout ratio of 24.1% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Humana to earn $16.02 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 22.1%.
Humana Stock Performance
NYSE:HUM opened at $415.55 on Friday. The stock's 50-day simple moving average is $400.25 and its 200 day simple moving average is $308.01. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $49.90 billion, a PE ratio of 39.31, a price-to-earnings-growth ratio of 2.54 and a beta of 0.74. Humana has a twelve month low of $163.11 and a twelve month high of $456.50.
Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the firm earned $6.27 earnings per share. Humana's revenue for the quarter was up 26.2% on a year-over-year basis. On average, analysts anticipate that Humana will post 9.03 EPS for the current fiscal year.
About Humana
(
Get Free Report)
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company's primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.